A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study

  • Ighovwerha Ofotokun
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
  • Anandi N. Sheth
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
  • Sara E. Sanford
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
  • Kirk A. Easley
    Emory University Center for AIDS Research, Atlanta, Georgia.
  • Neeta Shenvi
    Emory University School of Public Health, Biostatistics and Bioinformatics, Atlanta, Georgia.
  • Kelly White
    Abbott Laboratories, Abbott Park, Illinois.
  • Molly E. Eaton
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
  • Carlos Del Rio
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
  • Jeffrey L. Lennox
    Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ